Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2

First Page		Document Content
Date: 2015-04-01 04:38:50 Multiple sclerosis Medicine Immunology Clinical medicine Autoimmune diseases Neurological disorders Neurology Management of multiple sclerosis Glatiramer acetate Immunosuppressants McDonald criteria Diagnostic criteria for MS		Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2 Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 240,99 KB Share Document on Facebook

	25SA16A ________________________________________________________________________________________________________ Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases Anthony DocID: 1voae - View Document
	National Institute of Allergy and Infectious Diseases Awards MERS/SARS Coronavirus Drug Research Grant to Autoimmune Technologies FOR IMMEDIATE RELEASE New Orleans, June 24, Autoimmune Technologies LLC, a New Orle DocID: 1uTGp - View Document
	The Microbiome, which feeds a myriad of Autoimmune Diseases PRESENTED BY PROFESSOR TREVOR G MARSHALL Autoimmunity Research Foundation, CA, USA Murdoch University, Western Australia Autoimmunity Congress Granada, Spain, M DocID: 1upLN - View Document
	BioMed 258 Final Paper Eve Nakamura Autoimmune Cytopenias Autoimmune diseases are caused by a combination of genetic, epigenetic, and environmental factors and DocID: 1u7zf - View Document
	Overview ActoBiotics® Platform: A Novel Class of Oral Biotherapeutics DocID: 1rtnN - View Document